Activate Multilineage Defense Against Infection

LEUKINE® (sargramostim) is the first and only FDA-approved GM-CSF1

GM-CSF=granulocyte-macrophage colony-stimulating factor.

The unique multipotent biology of LEUKINE stimulates multiple immune cell types1

Explore the mechanism

Learn about LEUKINE prescribing, efficacy, safety, and more from a LEUKINE Clinical Science Specialist (CSS)


Your Clinical Science Specialist will serve as a comprehensive source of information about LEUKINE, including resources that may help your patients with cost of treatment.

Complete the required fields below to connect with your LEUKINE Clinical Science Specialist.

    *Indicates required field.

    Take a brief survey about your treatment approaches after transplant

    A donation will be made upon completion of the survey to support patients navigating the transplant journey.

    Take the survey